NCT04379583

HairDx Analytical Validation Study

• Status: Withdrawn
• Phase: —
• Study type: Observational
• Enrollment: 0 (actual)
• Sponsor: Applied Biology, Inc. · Industry
• Sex: Female
• Age: 18 Years
• Healthy volunteers: —

Summary

The HairDx Test reports genetic variants associated with the development of FPHL.

Detailed description

The HairDx Test reports genetic variants associated with the development of FPHL. The variants are detected from a saliva sample collected at home. The HairDx Test report is designed to help individuals understand the meaning of their results and encourage a conversation with a healthcare professional. The information provided by the HairDx Test report is not intended to start, stop or change any course of treatment. The purpose of this study is to collect DNA samples from subjects. The DNA samples will be used for the analytical validation of the HairDx Test. The results of this study will not be shared with the subjects.

Conditions

• Hair Loss
• Hair Loss/Baldness
• Female Pattern Baldness
• Androgenetic Alopecia

Interventions

Type	Name	Description
DEVICE	HairDx Sample Collection Kit	Saliva collection using FDA OTC cleared sample collection device

Timeline

• Start date: 2020-06-15
• Primary completion: 2021-12-06
• Completion: 2021-12-06
• First posted: 2020-05-07
• Last updated: 2021-07-21

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study